Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Ascentage Pharma Group International (NASDAQ: AAPG)
AAPG Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-10.90%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
35.40%
AAPG Stock Analysis
AAPG
PE Ratio:
AAPG
PEG Ratio:
Not Available
AAPG
Forward EPS Growth (12 month):
0.00%
AAPG
PS Ratio:
20.4
AAPG
PSG Ratio:
-23
AAPG
Forward Revenue Growth (12 month):
-0.90%
AAPG Articles
No data was found